idiopathic pulmonary fibrosis

Phase 2 trial of FG-3019, anti-CTGF monoclonal antibody, in idiopathic pulmonary fibrosis (IPF): Preliminary safety and efficacy results
Ganesh Raghu, Mary Beth Scholand, Joao de Andrade, Lisa Lancaster, Jonathan Goldin, Seth Porter, Thomas Neff, Frank Valone, John Stauffer

European Respiratory Journal Sep 2012, 40 (Suppl 56) 2819;
The role of dynamic magnetic resonance imaging in the evaluation of pulmonary nodules and masses
Fatih Alper, Adile Tuba Polat Kurt, Yener Aydin, Mesut Ozgokce, Metin Akgun

European Respiratory Journal Sep 2012, 40 (Suppl 56) 379;
Selected clinical highlights from the 2012 ERS congress in Vienna
Maurizio Marvisi, Felix J.F. Herth, Sebastian Ley, Venerino Poletti, Niels H. Chavannes, Martijn A. Spruit, Enrico Clini, Vincent Cottin

European Respiratory Journal May 2013, 41 (5) 1219-1227; DOI: 10.1183/09031936.00182612
Club cells inhibit alveolar epithelial wound repair via TRAIL-dependent apoptosis
Khondoker M. Akram, Nicola J. Lomas, Monica A. Spiteri, Nicholas R. Forsyth

European Respiratory Journal Mar 2013, 41 (3) 683-694; DOI: 10.1183/09031936.00213411

Main menu